Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

NCT02032875 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Daclatasvir
DRUG: Sofosbuvir
DRUG: Ribavirin

Sponsor

Bristol-Myers Squibb